8x8 Inc (EGHT) Moves Lower on Volume Spike for June 16

Equities Staff |

8x8 Inc (EGHT) traded on unusually high volume on Jun. 16, as the stock lost 0.34% to close at $14.75. On the day, 8x8 Inc saw 2.31 million shares trade hands on 7,759 trades. Considering that the stock averages only a daily volume of 930,043 shares a day over the last month, this represents a pretty significant bump in volume over the norm.

Generally speaking, when a stock experiences a sudden spike in trading volume, it may be seen as a bullish signal for investors. An increase in volume means more market awareness for the company, potentially setting up a more meaningful move in stock price. The added volume also provides a level of support and stability for price advances.

The stock has traded between $16.80 and $12.60 over the last 52-weeks, its 50-day SMA is now $14.00, and its 200-day SMA $14.56. 8x8 Inc has a P/B ratio of 4.68.

8x8 Inc is a technology company. It provides cloud-based, enterprise-class software solutions that transform the way businesses communicate and collaborate globally. The company operates through two segments: America and Europe.

Headquartered in San Jose, CA, 8x8 Inc has 1,019 employees and is currently under the leadership of CEO Vikram Verma.

For a complete fundamental analysis analysis of 8x8 Inc, check out Equities.com’s Stock Valuation Analysis report for EGHT.

Want to invest with the experts? Subscribe to Equities Premium newsletters today! Visit http://www.equitiespremium.com/ to learn more about Guild Investment’s Market Commentary and Adam Sarhan’s Find Leading Stocks today.

To get more information on 8x8 Inc and to follow the company’s latest updates, you can visit the company’s profile page here: EGHT’s Profile. For more news on the financial markets and emerging growth companies, be sure to visit Equities.com’s Newsdesk. Also, don’t forget to sign-up for our daily email newsletter to ensure you don’t miss out on any of our best stories.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.



DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

iPRO Network, LLC

We provide the platform, tools, and resources to empower individuals and professionals to market desirable goods and services to the public, taking the place of traditional methods of commerce.

Voleo

Voleo is a free download that allows you to form investment clubs with your friends, family, colleagues, classmates, teammates…basically anyone you know and trust. Invest and manage a stock portfolio…